B-Cell Proliferation of Uncertain Malignant Potential

B-Cell Proliferation of Uncertain Malignant Potential — Trials · CancerIndex

Clinical trials

Registered studies

83 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–83 of 83 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01045928	Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma	terminated	Phase 1	5	Case Comprehensive Cancer CenterOTHER	1	Nov 26, 2015	clinicaltrials
NCT02109224	Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection	terminated	Phase 1	72	National Cancer Institute (NCI)NIH	1	Aug 20, 2015	clinicaltrials
NCT01658319	Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies	completed	Phase 1	20	Case Comprehensive Cancer CenterOTHER	1	Aug 13, 2015	clinicaltrials
NCT01959477

Data updated 23 days agoSource updated Nov 26, 2015source: clinicaltrials